BAVIS_1170x120_1-20

Nick Spring

FDA completes review investigational new drug application from BioSig

FDA completes review investigational new drug application from BioSig

WESTPORT, Conn.— BioSig Technologies announced that the U.S. Food and Drug Administration (FDA) has completed its review of ViralClear’s Investigational New Drug (IND) application. The FDA informed ViralClear that it may proceed with a proposed phase II study of merimepodib oral solution in adults with COVID-19 who are hospitalized and either require supplemental oxygen or

Reliefband lands distribution with AmerisourceBergen

Reliefband lands distribution with AmerisourceBergen

HORSHAM, Pa. — Reliefband Technologies LLC, maker of the Reliefband wearable device for motion sickness, has entered a distribution partnership with AmerisourceBergen Corp. Reliefband said Tuesday that the partnership enables AmerisourceBergen to provide the clinically proven Reliefband technology to retail pharmacies and health care providers nationwide. The watchlike device will be available over-the-counter at AmerisourceBergen’s